These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 23929016)

  • 21. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5.
    Prescott NJ; Fisher SA; Franke A; Hampe J; Onnie CM; Soars D; Bagnall R; Mirza MM; Sanderson J; Forbes A; Mansfield JC; Lewis CM; Schreiber S; Mathew CG
    Gastroenterology; 2007 May; 132(5):1665-71. PubMed ID: 17484864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
    Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians.
    Juyal G; Amre D; Midha V; Sood A; Seidman E; Thelma BK
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1325-32. PubMed ID: 17892524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases].
    Heresbach D; Ababou A; Bourienne A; Alizadeh M; Quelvennec E; Pagenault M; Dabadie A; Berre NH; Campion JP; Launois B; Gosselin M; Genetet B; Bretagne JF; Semana G
    Gastroenterol Clin Biol; 1997; 21(8-9):555-61. PubMed ID: 9587492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The -A2518G polymorphism of monocyte chemoattractant protein-1 is associated with Crohn's disease.
    Palmieri O; Latiano A; Salvatori E; Valvano MR; Bossa F; Latiano T; Corritore G; di Mauro L; Andriulli A; Annesec V
    Am J Gastroenterol; 2010 Jul; 105(7):1586-94. PubMed ID: 20125127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms of interleukin-23 receptor in patients with inflammatory bowel disease in a Croatian tertiary center.
    Mihaljević S; Kibel A; Stefanić M; Glavas-Obrovac L; Takac B; Krznarić Z; Samardiija M; Pinotić L; Milas J; Segec I
    Coll Antropol; 2013 Dec; 37(4):1171-7. PubMed ID: 24611330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.
    Takač B; Mihaljević S; Glavaš-Obrovac L; Kibel A; Suver-Stević M; Canecki-Varžić S; Samardžija M; Rajkovac I; Kovač D; Štefanić M
    Acta Clin Croat; 2020 Mar; 59(1):67-80. PubMed ID: 32724277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of surgically treated Crohn's colitis: a prospective study.
    Fichera A; McCormack R; Rubin MA; Hurst RD; Michelassi F
    Dis Colon Rectum; 2005 May; 48(5):963-9. PubMed ID: 15785882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease.
    Papa A; Pola R; Flex A; Danese S; Armuzzi A; Gaetani E; Guidi L; De Vitis I; Urgesi R; Grillo A; Serricchio M; Proia AS; Fedeli G; Gasbarrini G; Pola P; Gasbarrini A
    Dig Liver Dis; 2004 Aug; 36(8):528-32. PubMed ID: 15334773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients.
    Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Bossa F; Latiano T; Devoto M; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1129-38. PubMed ID: 16305727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.
    Török HP; Glas J; Tonenchi L; Lohse P; Müller-Myhsok B; Limbersky O; Neugebauer C; Schnitzler F; Seiderer J; Tillack C; Brand S; Brünnler G; Jagiello P; Epplen JT; Griga T; Klein W; Schiemann U; Folwaczny M; Ochsenkühn T; Folwaczny C
    Gut; 2005 Oct; 54(10):1421-7. PubMed ID: 15955786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.